Amgen Deploys up to 1,000 Reps on Prolia Approval

mmm-online.com -- Amgen has deployed “500 to 1,000” reps in support of Prolia (denosumab), a biologic osteoporosis treatment that received FDA approval on June 1. The drug was approved in the European Union on May 28.